Eric Keisman
Partner

Eric Keisman joined Flagship Pioneering in 2023 as a Partner. He works with Flagship Growth companies on scientific and pipeline strategy, to help them align their platforms with value creation opportunities.
Eric comes to Flagship with 21 years of experience in pharmaceutical and biotechnology company analysis, gained as an investor and industry analyst at the Capital Group Companies. At Capital, Eric led portfolio investments across the European and Japanese pharmaceutical and biotechnology sectors.
Prior to joining Capital, Eric received his Ph.D. in Developmental Genetics at Stanford University, previously earned a B.S. in Physics from the University of Massachusetts, and holds a CFA designation. Eric also performed research in immunology at The John’s Hopkins University, focused on mechanisms of genetic diversification of the antibody repertoire.
